Trade Greenwich LifeSciences, Inc. - GLSI CFD

Add to favourite

11.91

0.75%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.33

Long position overnight fee

-0.023512%

Short position overnight fee

0.00129%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	12
Open	11.87
1-Year Change	-6.76%
Day's Range	11.84 - 12.18

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Feb 21, 2025	11.91	0.04	0.34%	11.87	12.25	11.76
Feb 20, 2025	12.00	-0.31	-2.52%	12.31	12.57	11.76
Feb 19, 2025	12.55	0.59	4.93%	11.96	12.80	11.96
Feb 18, 2025	12.41	0.30	2.48%	12.11	12.62	12.11
Feb 14, 2025	12.27	0.27	2.25%	12.00	12.39	11.90
Feb 13, 2025	12.25	0.79	6.89%	11.46	12.31	11.46
Feb 12, 2025	11.93	0.12	1.02%	11.81	12.08	11.51
Feb 11, 2025	11.97	-0.32	-2.60%	12.29	12.46	11.81
Feb 10, 2025	12.18	0.21	1.75%	11.97	12.52	11.96
Feb 7, 2025	12.36	0.00	0.00%	12.36	12.36	11.96
Feb 6, 2025	12.40	-0.26	-2.05%	12.66	12.78	12.01
Feb 5, 2025	12.58	0.12	0.96%	12.46	12.87	12.41
Feb 4, 2025	12.63	-0.12	-0.94%	12.75	12.87	12.47
Feb 3, 2025	12.77	0.31	2.49%	12.46	12.90	12.31
Jan 31, 2025	12.90	-0.06	-0.46%	12.96	13.47	12.68
Jan 30, 2025	13.02	0.06	0.46%	12.96	13.26	12.54
Jan 29, 2025	13.21	0.12	0.92%	13.09	13.34	12.93
Jan 28, 2025	13.08	-0.13	-0.98%	13.21	13.58	12.81
Jan 27, 2025	13.23	0.75	6.01%	12.48	14.35	12.45
Jan 24, 2025	13.05	0.27	2.11%	12.78	13.11	12.26

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Greenwich LifeSciences, Inc. Company profile

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent recurrence of breast cancer following surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Industry:

Biopharmaceuticals

3992 Bluebonnet Dr, Building 14
STAFFORD
TEXAS 77477
US

News

Microsoft Stock Price Forecast for 2025 and beyond: Third party price target

We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...

18:29, 7 February 2025

Ripple XRP price prediction: Third-party price target

Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com

15:29, 6 February 2025

Apple Store on Fifth Avenue, New York, October 2016

Apple (AAPL) stock price forecast: third-party price target

We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.

11:22, 6 February 2025